Last reviewed · How we verify

NCT04933838

Effectiveness and Safety of Atelocollagen in the Management of Chronic Non-specific Low Back Pain

Completed NA Last updated 14 September 2022
What this trial tests

NA trial testing atelocollagen in Low Back Pain in 34 participants. Completed in 27 April 2022.

Timeline
1 July 2021
Primary endpoint
3 March 2022
27 April 2022

Quick facts

Lead sponsorSeoul National University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment34
Start date1 July 2021
Primary completion3 March 2022
Estimated completion27 April 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University

Who can join

19 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to evaluate the effectiveness and safety of atelocollagen in the management of chronic low back pain with sarcopenia due to degenerative changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Seoul National University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04933838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing